Exelixis
EXEL
#2109
Rank
โ‚น632.25 B
Marketcap
โ‚น2,216
Share price
-1.53%
Change (1 day)
23.95%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: โ‚น632.25 Billion

As of September 2024 Exelixis has a market cap of โ‚น632.25 Billion. This makes Exelixis the world's 2109th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2024

End of year Market Cap

Year Market cap Change
2024โ‚น632.25 B1.8%
2023โ‚น621.05 B45.06%
2022โ‚น428.13 B-0.67%
2021โ‚น431.02 B-5.19%
2020โ‚น454.61 B19.3%
2019โ‚น381.08 B-7.12%
2018โ‚น410.30 B-28.55%
2017โ‚น574.27 B95.49%
2016โ‚น293.75 B243.86%
2015โ‚น85.42 B378.54%
2014โ‚น17.85 B-74.46%
2013โ‚น69.90 B52.07%
2012โ‚น45.97 B35.38%
2011โ‚น33.95 B-15.58%
2010โ‚น40.22 B8.57%
2009โ‚น37.04 B40.59%
2008โ‚น26.35 B-26.07%
2007โ‚น35.64 B-6.84%
2006โ‚น38.26 B8.22%
2005โ‚น35.35 B26.18%
2004โ‚น28.02 B22.21%
2003โ‚น22.92 B0.64%
2002โ‚น22.78 B-49.4%
2001โ‚น45.02 B41.16%
2000โ‚น31.89 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Exelixis was reported to be:

โ‚น632.25 Billion
by Yahoo Finance info icon info icon
โ‚น632.25 Billion
by CompaniesMarketCap info icon info icon
โ‚น632.25 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
โ‚น7.084 T 1,020.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น12.120 T 1,816.99%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น24.916 T 3,840.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น8.403 T 1,229.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น15.208 T 2,305.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น33.152 T 5,143.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น13.986 T 2,112.13%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.96 B-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น43.74 B-93.08%๐Ÿ‡บ๐Ÿ‡ธ USA